| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/11/1993 | WO1993022435A1 Fanconi anemia gene for complementation group c |
| 11/11/1993 | WO1993022432A1 Method for identifying transgenic preimplantation embryos |
| 11/11/1993 | WO1993022431A1 Constitutive and inducible epidermal vector systems |
| 11/11/1993 | WO1993022430A1 Development of a vector to target gene expression to the epidermis of transgenic animals |
| 11/11/1993 | WO1993022429A1 Novel compositions and methods for detection and treatment of human osteoarthritis |
| 11/11/1993 | WO1993022425A1 Improved recombinant protein production |
| 11/11/1993 | WO1993022424A1 RECOMBINANT STIMULATING FACTOR OF THE neu RECEPTOR |
| 11/11/1993 | WO1993022422A1 Genetically engineered eukaryotic organism capable of detecting the expression of heterologous ion channels |
| 11/11/1993 | WO1993022348A1 Production of recombinant human lactoferrin |
| 11/11/1993 | WO1993022347A1 Cytokine-like molecule and bioassay therefor |
| 11/11/1993 | WO1993022346A1 A novel anti-neoplastic cytokine |
| 11/11/1993 | WO1993022345A1 Novel plant virus sequences |
| 11/11/1993 | WO1993022344A1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin |
| 11/11/1993 | WO1993022343A1 Multiple antigen peptide system having adjuvant properties and vaccines prepared therefrom |
| 11/11/1993 | WO1993022342A1 Protein l and hybrid proteins thereof |
| 11/11/1993 | WO1993022341A1 Synthetic peptide vaccines for dental caries |
| 11/11/1993 | WO1993022340A1 Modulation of thrombospondin-cd36 interactions |
| 11/11/1993 | WO1993022339A1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR |
| 11/11/1993 | WO1993022338A1 Peptides of human papilloma virus for use in human t cell response inducing compositions |
| 11/11/1993 | WO1993022337A1 Factor viii purification process |
| 11/11/1993 | WO1993022336A1 Improved solubilization and stabilization of factor viii complex |
| 11/11/1993 | WO1993022335A1 Stable polypeptide composition |
| 11/11/1993 | WO1993022332A2 Recombinant production of immunoglobulin-like domains in prokaryotic cells |
| 11/11/1993 | WO1993022331A1 Human crabp-i and crabp-ii |
| 11/11/1993 | WO1993021962A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
| 11/11/1993 | WO1993021958A1 Human papilloma virus genes and their use in gene therapy |
| 11/11/1993 | WO1993021957A1 Complexing agents and targeting immunoreagents |
| 11/11/1993 | WO1993021956A1 Antibodies to p-selectin and their uses |
| 11/11/1993 | WO1993021954A1 Slip1/sulfated-glyco moiety interfering compositions and methods for inhibition of fertilization |
| 11/11/1993 | WO1993021952A1 Human monoclonal antibodies against cytomegalovirus and method for preparation thereof |
| 11/11/1993 | WO1993021948A1 Peptide-carbohydrate conjugates generating t-cell immunity |
| 11/11/1993 | WO1993021947A1 Improved production of reproductive hormones |
| 11/11/1993 | WO1993021944A1 Methods of treating cancer using modified c-reactive protein |
| 11/11/1993 | WO1993021937A1 Non-bitter protein hydrolyzates |
| 11/11/1993 | WO1993021936A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF |
| 11/11/1993 | WO1993021769A1 Diphtheria toxin receptor-binding region |
| 11/11/1993 | WO1993020238A3 Amplification of human mdm2 gene in human tumors |
| 11/11/1993 | WO1993020103A3 Peptides of an antigen, capable of recognition by or induction of cytotoxic t lymphocytes, and method of their identification |
| 11/11/1993 | WO1993019202A3 Exchangeable template reaction |
| 11/11/1993 | WO1993018163A3 Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria |
| 11/11/1993 | WO1993018146A3 Proteins forming complexes with chaperones and ligands thereof, fragments thereof, preparation thereof and biological uses thereof |
| 11/11/1993 | WO1993017712A3 Conjugates formed from heat shock proteins and oligo- or polysaccharides |
| 11/11/1993 | CA2135207A1 Protein l and process for its preparation by recombinant dna technology |
| 11/11/1993 | CA2135059A1 Complexing agents and targeting immunoreagents |
| 11/11/1993 | CA2135052A1 Diphtheria toxin receptor-binding region |
| 11/11/1993 | CA2134784A1 Novel plant virus sequences |
| 11/11/1993 | CA2134678A1 Fanconi anemia gene for complementation group c |
| 11/11/1993 | CA2134675A1 Development of a vector to target gene expression to the epidermis of transcenic animals |
| 11/11/1993 | CA2134670A1 Constitutive and inducible epidermal vector systems |
| 11/11/1993 | CA2134666A1 Cdna sequence of dengue virus serotype 1 (singapore strain) |
| 11/11/1993 | CA2134655A1 Modulation of thrombospondin-cd36 interactions |
| 11/11/1993 | CA2134564A1 Recombinant stimulating factor of the neu receptor |
| 11/11/1993 | CA2134550A1 Human crabp-i and crabp-ii |
| 11/11/1993 | CA2134544A1 Binding peptides which interact with ligand growth factors of the epidermal growth factor receptor and erbb-2 receptor |
| 11/11/1993 | CA2134443A1 Inhibitory factor |
| 11/11/1993 | CA2134337A1 Oligonucleotides and nucleic acids for detection of ureaplasma urealyticum |
| 11/11/1993 | CA2134198A1 Improved recombinant protein production |
| 11/11/1993 | CA2134097A1 Peptide-carbohydrate conjugates generating t-cell immunity |
| 11/11/1993 | CA2133581A1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin |
| 11/11/1993 | CA2118513A1 In vivo homologous sequence targeting in eukaryotic cells |
| 11/11/1993 | CA2118508A1 Recombinant production of immunoglobulin-like domains in prokaryotic cells |
| 11/11/1993 | CA2118320A1 Production of reproductive hormones |
| 11/11/1993 | CA2118128A1 Non-bitter protein hydrolyzates |
| 11/11/1993 | CA2112798A1 Peptides of human papilloma virus for use in human t cell response inducing compositions |
| 11/11/1993 | CA2101734A1 Compounds and conjugates |
| 11/10/1993 | EP0569309A1 Hepatitis C virus synthetic polypeptides usable for detection of the virus |
| 11/10/1993 | EP0569240A1 Human metabotropic glutamate receptor and related DNA compounds |
| 11/10/1993 | EP0569042A1 Medical uses of IL-1 beta |
| 11/10/1993 | EP0568925A2 TNF receptor action modulation |
| 11/10/1993 | EP0568836A1 Plasminogen activator inhibitor 2 purification using immunoaffinity chromatography |
| 11/10/1993 | EP0568833A1 Human antithrombin III mutants |
| 11/10/1993 | EP0568687A1 Novel amylin antagonist peptides and uses therefor |
| 11/10/1993 | EP0568645A1 Mixed specificity fusion proteins |
| 11/10/1993 | EP0568623A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 11/10/1993 | EP0568622A1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp) |
| 11/10/1993 | EP0568575A1 Test and model for alzheimer's disease |
| 11/10/1993 | EP0568539A1 Soluble mannose receptor peptides |
| 11/10/1993 | EP0568537A1 Genetic modification of endothelial cells |
| 11/10/1993 | EP0552302A4 Method of inhibiting transcription utilizing nuclear receptors |
| 11/10/1993 | EP0516704B1 Novel insulin compositions |
| 11/10/1993 | EP0407411B1 ACTIVITION OF NF-kB PRECURSOR |
| 11/10/1993 | CN1078153A Methods for using histamine derivatives as immunomodulators and in immunotherapeutics |
| 11/09/1993 | US5260434 DNA encoding IgE-binding protein with repetitive sequence and homology with IgG receptor |
| 11/09/1993 | US5260432 Genetic engineering |
| 11/09/1993 | US5260429 Purified DNA of the 170-kd surface Gal/GalNAc adherence lectin of pathogenic E. histolytica |
| 11/09/1993 | US5260422 MHC conjugates useful in ameliorating autoimmunity |
| 11/09/1993 | US5260421 Site-directed mutagenesis modified glycoprotein hormones |
| 11/09/1993 | US5260419 Cation exchange resin |
| 11/09/1993 | US5260417 Megakaryocyte growth promoting activity protein |
| 11/09/1993 | US5260416 Antigenic epitopes present on membrane-bound but not secreted IgE |
| 11/09/1993 | US5260373 Immobilized immunoglobulin-binding proteins |
| 11/09/1993 | US5260308 Proteins glycated with glucose |
| 11/09/1993 | US5260276 Hypotensive agents, treatment of myocardial infraction, congestive heart failure, endotoxic shock, antiarrythmia agents |
| 11/09/1993 | US5260275 Glibenclamide and tolbutamide for treating non-insulin dependent, or type 2, diabetes mellitus; enhance plasma concentration of amylin |
| 11/09/1993 | US5260274 Factor VIII binding domain of von Willebrand Factor |
| 11/09/1993 | US5260273 Pulmonary surfactant protein and related polypeptide |
| 11/09/1993 | US5260272 Dnetistry, biofouling |
| 11/09/1993 | US5260270 Applying to human nose to effect binding and concentrate odorants |
| 11/09/1993 | US5260224 Tissue injury prevention |
| 11/09/1993 | US5260223 Methods for detection of human gamma, γ T cell receptor |